{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:11:21Z","timestamp":1762193481969,"version":"build-2065373602"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,3]]},"DOI":"10.7759\/cureus.96014","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:00:17Z","timestamp":1762192817000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond the Obstruction: Recognising Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Plasma Cell Disorder, and Skin Changes (POEMS) Syndrome in a Patient With Budd-Chiari Syndrome"],"prefix":"10.7759","author":[{"given":"Shadman Sakib","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kh Imranul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusrat A","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Ul Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Al Amin","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumaiya","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Alegbeleye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25495","article-title":"POEMS syndrome: 2019 update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri A","year":"2019","unstructured":"Dispenzieri A. POEMS syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol. 2019, 94:812-27. 10.1002\/ajh.25495","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008062","article-title":"Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey","volume":"93","author":"Suichi T","year":"2019","unstructured":"Suichi T, Misawa S, Beppu M, et al.. Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey. Neurology. 2019, 93:e975-83. 10.1212\/WNL.0000000000008062","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri A","year":"2003","unstructured":"Dispenzieri A, Kyle RA, Lacy MQ, et al.. POEMS syndrome: definitions and long-term outcome. Blood. 2003, 101:2496-506. 10.1182\/blood-2002-07-2299","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009157","article-title":"Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study","volume":"5","author":"Misawa S","year":"2015","unstructured":"Misawa S, Sato Y, Katayama K. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study. BMJ Open. 2015, 5:e009157.","journal-title":"BMJ Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000796","article-title":"Comprehensive diagnosis and management of POEMS syndrome","volume":"6","author":"D'Sa S","year":"2022","unstructured":"D'Sa S, Khwaja J, Keddie S, et al.. Comprehensive diagnosis and management of POEMS syndrome. Hemasphere. 2022, 6:e796. 10.1097\/HS9.0000000000000796","journal-title":"Hemasphere"},{"key":"ref6","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","author":"D\u2019Souza A","year":"2011","unstructured":"D\u2019Souza A, Hayman SR, Buadi F. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood. 2011, 118:4663-4665.","journal-title":"Blood"},{"key":"ref7","article-title":"Plexogenic pulmonary hypertension associated with POEMS syndrome","volume":"22","author":"Czeczok T","year":"2017","unstructured":"Czeczok T, Lin P, Yi E. Plexogenic pulmonary hypertension associated with POEMS syndrome. Respir Med Case Rep. 2017, 22:168-70.","journal-title":"Respir Med Case Rep"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2020-141078","article-title":"Efficacy and safety of regimens used for the treatment of POEMS syndrome-a systematic review","volume":"136","author":"Faizan U","year":"2020","unstructured":"Faizan U, Farooqi MS, Imtiaz H. Efficacy and safety of regimens used for the treatment of POEMS syndrome-a systematic review. Blood. 2020, 136:7.","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-023-00859-x","article-title":"Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: the Mayo Clinic experience","volume":"13","author":"Vaxman I","year":"2023","unstructured":"Vaxman I, Kumar SK, Buadi F, et al.. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: the Mayo Clinic experience. Blood Cancer J. 2023, 13:91.","journal-title":"Blood Cancer J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/427798-beyond-the-obstruction-recognising-polyneuropathy-organomegaly-endocrinopathy-monoclonal-plasma-cell-disorder-and-skin-changes-poems-syndrome-in-a-patient-with-budd-chiari-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:00:18Z","timestamp":1762192818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/427798-beyond-the-obstruction-recognising-polyneuropathy-organomegaly-endocrinopathy-monoclonal-plasma-cell-disorder-and-skin-changes-poems-syndrome-in-a-patient-with-budd-chiari-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.96014","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,3]]}}}